Galapagos | GLPG - Despesas Operacionais

Preço das Ações
27.72
Mudança Diária
-0.30 -1.07%
Mensal
-2.26%
Anual
16.57%
Q1 Previsão
27.46




Despesas Operacionais Alterar Data
argenx SE USD 914.57M 137.58M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Biogen USD 1.88B 81.4M 2025-09
Genmab DKK 565M 38M 2025-06
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
GRIFOLS EUR 1.71B 193M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Incyte USD 1.12B 3.53B 2025-12
Merck EUR 4.78B 669M 2025-12
Neurocrine Biosciences USD 577.6M 22M 2025-12
Novartis USD 9.86B 115M 2025-09
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
UCB EUR 2.36B 108M 2024-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12